Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0.88%
1,100.61
-9.73
-0.88%
—1,110.341,110.371,117.241,097.84——
SIXC
Communications
SIXC
Communications
SIXC
-1.33%
612.30
-8.24
-1.33%
—620.54620.54622.67611.42——
SIXE
Energy
SIXE
Energy
SIXE
+1.40%
1,175.46
+16.26
+1.40%
—1,159.201,160.591,177.621,156.21——
SIXI
Industrials
SIXI
Industrials
SIXI
-1.39%
1,729.12
-24.32
-1.39%
—1,753.441,749.081,762.011,724.74——
SIXM
Financials
SIXM
Financials
SIXM
-0.63%
644.73
-4.07
-0.63%
—648.80649.58655.73643.68——
SIXR
Staples
SIXR
Staples
SIXR
-0.65%
827.09
-5.40
-0.65%
—832.49832.07833.09826.15——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-1.98%
214.82
-4.34
-1.98%
—219.16219.16219.19214.82——
SIXT
Technology
SIXT
Technology
SIXT
+0.06%
3,115.17
+1.81
+0.06%
—3,113.363,120.793,143.643,105.16——
SIXU
Utilities
SIXU
Utilities
SIXU
-1.75%
910.43
-16.24
-1.75%
—926.67927.99930.54910.08——
SIXV
Health care
SIXV
Health care
SIXV
-1.01%
1,474.50
-15.11
-1.01%
—1,489.611,499.051,499.051,474.35——
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0.72%
2,405.87
-17.39
-0.72%
—2,423.262,438.162,443.462,399.83——
CUP:FRA
Chugai Pharmaceutical Co Ltd
€45.83
-1.95%
(-0.91) 1D
Apr 21, 10:00:00 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for CUP...
Open
€45.88
High
€45.89
Low
€45.83
Mkt. cap
14.60T
Avg. vol.
21.00
Volume
0.00
52-wk high
€56.26
52-wk low
€33.02
No. of employees
5K
News stories
From sources across the web
Profile
Chugai Pharmaceutical Co., Ltd. is a drug manufacturer operating in Japan. It is a subsidiary controlled by Hoffmann-La Roche, which owns 62% of the company as of 30 June 2014. The company is headquartered in Tokyo. Osamu Nagayama is the current representative director and chairman. Tatsuro Kosaka is the current representative director, president and CEO. Wikipedia
About Chugai Pharmaceutical Co Ltd
CEOOsamu Okuda
Employees5.1K
FoundedMar 10, 1925
Headquarters-
SectorPharmaceutical industry
Websitechugai-pharm.co.jp
Previous reportsAll values in JPY
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in JPY
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
288.46B
290.00B
333.18B
346.30B
Cost of goods sold
87.82B
88.07B
100.24B
87.56B
Cost of revenue
87.82B
88.07B
100.24B
87.56B
Research and development expenses
40.93B
45.66B
48.60B
52.41B
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
23.24B
28.41B
27.89B
36.92B
Operating expense
63.99B
65.24B
76.45B
89.74B
Total operating expenses
151.81B
153.31B
176.69B
177.30B
Operating income
136.65B
136.69B
156.48B
169.01B
Other non operating income
-824.00M
-633.00M
-356.00M
994.00M
EBT including unusual items
135.83B
136.00B
156.07B
169.90B
EBT excluding unusual items
135.83B
136.00B
156.07B
169.90B
Income tax expense
38.60B
38.85B
44.86B
41.50B
Effective tax rate
28.41%
28.56%
28.74%
24.42%
Other operating expenses
-178.00M
-8.83B
-38.00M
405.00M
Net income
97.23B
97.16B
111.21B
128.41B
Net profit margin
33.71%
33.50%
33.38%
37.08%
Earnings per share
-
-
-
-
Interest and investment income
3.00M
-
-
-
Interest expense
-
-57.00M
-58.00M
-95.00M
Net interest expenses
3.00M
-57.00M
-58.00M
-95.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
137.05B
137.09B
156.78B
200.44B
Gain or loss from assets sale
-
-
-
4.53B
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer